Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05394168 2024-04-01

A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors

Phase 1 Unknown

12 enrolled

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT05037149 2024-03-18

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

Phase 1 Unknown

50 enrolled

Other solid neoplasm

Solid Tumor

NCT05798026 2024-03-13

A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy

Phase 1 Unknown

15 enrolled

Other solid neoplasm

Solid Tumor

NCT06139536 2024-03-13

Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients

Phase 1 Unknown

210 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05103046 2024-03-12

First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors

Phase 1 Unknown

68 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05836623 2024-02-28

A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

Phase 1 Unknown

5 enrolled

Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

NCT06281860 2024-02-28

PITHAC

Phase 1 Unknown

39 enrolled

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT05971862 2024-02-21

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors

Phase 1 Unknown

36 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05367232 2024-02-07

A Study of ICP-033 in Patients With Advanced Solid Tumors

Phase 1 Unknown

60 enrolled

Other solid neoplasm

Patients With Advanced Solid Tumors

NCT06240767 2024-02-05

Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

Phase 1 Unknown

18 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT05291182 2024-02-02

A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors

Phase 1 Unknown

40 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06232863 2024-02-02

A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer

Phase 1 Unknown

24 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT05388487 2024-01-16

Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors

Phase 1 Unknown

54 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT06001684 2024-01-03

Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors

Phase 1 Unknown

18 enrolled

Other solid neoplasm

Solid Tumors

NCT05164458 2023-12-28

Safety and Efficacy of IBI389 Single Agent, and in Combination With Sintilimab, in Patients With Advanced Malignancies

Phase 1 Unknown

320 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT04739293 2023-12-07

Study of ON 123300 in Patients With Advanced Cancer

Phase 1 Unknown

36 enrolled

Other solid neoplasm

Solid Tumors, Adult

NCT06154343 2023-12-04

A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors

Phase 1 Unknown

150 enrolled

Other solid neoplasm

HER2 Expressing or Mutated Advanced Malignant Solid Tumors

NCT05886868 2023-11-29

Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors

Phase 1 Unknown

66 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04190823 2023-11-27

A Study of RC98 in Subjects With Advanced Malignant Solid Tumors

Phase 1 Unknown

63 enrolled

Other solid neoplasm

Solid Tumors

NCT04894825 2023-11-27

Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China

Phase 1 Unknown

152 enrolled

Other solid neoplasm

Advanced Unresectable Solid Tumors

NCT05101265 2023-11-27

Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment

Phase 1 Unknown

24 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04839991 2023-11-18

POTENTIA

Phase 1 Unknown

70 enrolled

Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

NCT04294576 2023-11-09

FIH

Phase 1 Unknown

92 enrolled

Other solid neoplasm

Locally Advanced/Metastatic Solid Tumors

NCT05681000 2023-11-09

Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

Phase 1 Unknown

28 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06116240 2023-11-03

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

Phase 1 Unknown

135 enrolled

Other solid neoplasm

Solid Tumor

NCT04156347 2023-10-31

Topotecan Episcleral Plaque for Treatment of Retinoblastoma

Phase 1 Unknown

42 enrolled

Other solid neoplasm

Retinoblastoma

NCT05498597 2023-10-19

AMT-151 in Patients With Selected Advanced Solid Tumours

Phase 1 Unknown

30 enrolled

BreastGynecologicOther solid neoplasmThoracic

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05263180 2023-10-18

A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors.

Phase 1 Unknown

30 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05267899 2023-09-26

A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors

Phase 1 Unknown

24 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06054932 2023-09-26

Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors

Phase 1 Unknown

18 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06047431 2023-09-21

A Study of QL1706H in Patients With Advanced Solid Tumors

Phase 1 Unknown

150 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05564806 2023-09-07

Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

Phase 1 Unknown

38 enrolled

LymphoidOther solid neoplasm

Advanced Solid Tumors

NCT06006793 2023-09-01

A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation

Phase 1 Unknown

50 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06019013 2023-08-31

A Study of QLF3108 in Participants With Advanced Solid Tumor

Phase 1 Unknown

78 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06015269 2023-08-29

Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

Phase 1 Unknown

200 enrolled

Other solid neoplasm

Solid Tumor

NCT04280341 2023-08-25

JS001 in Combination With RC48-ADC in Treatment of HER2-Positive Advanced Malignant Solid Tumors

Phase 1 Unknown

50 enrolled

Other solid neoplasm

HER2-Positive Solid Tumors

NCT05509985 2023-08-14

A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors

Phase 1 Unknown

100 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT04965220 2023-08-09

HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors

Phase 1 Unknown

220 enrolled

Other solid neoplasm

Solid Tumor

NCT05360381 2023-08-08

HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Unknown

82 enrolled

Other solid neoplasmThoracic

Locally Advanced or Metastatic Solid Tumors

NCT05976906 2023-08-04

Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors

Phase 1 Unknown

36 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05972460 2023-08-02

IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors

Phase 1 Unknown

108 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05884801 2023-08-01

Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors

Phase 1 Unknown

148 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04856150 2023-07-27

A Study of Q-1802 in Patients With Advanced Solid Tumors

Phase 1 Unknown

66 enrolled

Other solid neoplasm

Advanced Solid Tumors

Clinical Trials

Patriot

Phase I of XKH002 Injection in Patients

AMT-562 in Patients With Selected Advanced Solid Tumors

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

A Study to Investigate the Safety, Tolerability and Efficacy of HLX60 Combination With HLX10 in Subjects With Advanced or Metastatic Solid Tumors

Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy

Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients

First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors

A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

PITHAC

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors

A Study of ICP-033 in Patients With Advanced Solid Tumors

Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors

A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer

Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors

Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors

Safety and Efficacy of IBI389 Single Agent, and in Combination With Sintilimab, in Patients With Advanced Malignancies

Study of ON 123300 in Patients With Advanced Cancer

A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors

Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors

A Study of RC98 in Subjects With Advanced Malignant Solid Tumors

Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China

Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment

POTENTIA

FIH

Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

Topotecan Episcleral Plaque for Treatment of Retinoblastoma

AMT-151 in Patients With Selected Advanced Solid Tumours

A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors.

A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors

Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors

A Study of QL1706H in Patients With Advanced Solid Tumors

Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation

A Study of QLF3108 in Participants With Advanced Solid Tumor

Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

JS001 in Combination With RC48-ADC in Treatment of HER2-Positive Advanced Malignant Solid Tumors

A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors

HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors

HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors

Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors

IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors

Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors

A Study of Q-1802 in Patients With Advanced Solid Tumors